Acadia Pharmaceuticals
Encyclopedia
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin
, which is in Phase III clinical development as a treatment for Parkinson's disease
psychosis. It is also developing AGN XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma
, both in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development for schizophrenia in collaboration with Meiji Seika Kaisha
. The product candidates in the company's pipeline emanate from discoveries made using its proprietary drug discovery platform.
to March 2012. The agreement stipulates both parties will work together for the discovery of new therapeutics for glaucoma
and opthalmic conditions.
Pimavanserin
Pimavanserin is a drug developed by Acadia Pharmaceuticals which acts as an inverse agonist on the serotonin receptor subtype 5-HT2A, with 10x selectivity over 5-HT2C, and no significant affinity or activity at 5-HT2B or dopamine receptors...
, which is in Phase III clinical development as a treatment for Parkinson's disease
Parkinson's disease
Parkinson's disease is a degenerative disorder of the central nervous system...
psychosis. It is also developing AGN XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma
Glaucoma
Glaucoma is an eye disorder in which the optic nerve suffers damage, permanently damaging vision in the affected eye and progressing to complete blindness if untreated. It is often, but not always, associated with increased pressure of the fluid in the eye...
, both in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development for schizophrenia in collaboration with Meiji Seika Kaisha
Meiji Seika
is the trade name of a pharmaceutical company in Japan, , until March 31, 2011.It was the confectionery and pharmaceutical company that manufactures a wide range of products including Hello Panda and Yan Yan...
. The product candidates in the company's pipeline emanate from discoveries made using its proprietary drug discovery platform.
Recent Events
Acadia Pharmaceuticals extended its drug discovery and development research agreement with AllerganAllergan
Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.-Profile:...
to March 2012. The agreement stipulates both parties will work together for the discovery of new therapeutics for glaucoma
Glaucoma
Glaucoma is an eye disorder in which the optic nerve suffers damage, permanently damaging vision in the affected eye and progressing to complete blindness if untreated. It is often, but not always, associated with increased pressure of the fluid in the eye...
and opthalmic conditions.